Literature DB >> 2464554

Synaptophysin in the human retina and retinoblastoma. An immunohistochemical and Western blotting study.

T Kivelä1, A Tarkkanen, I Virtanen.   

Abstract

Fifty-four formalin-fixed and paraffin-embedded intraocular retinoblastoma specimens and three human eyes enucleated because of orbital tumors were studied for the presence of synaptophysin, a neuron-associated integral membrane glycoprotein of presynaptic vesicles, by using the monoclonal antibody SY38. Normal human brain was used as control. In the human retina, synaptophysin-like immunoreactivity was present in both plexiform layers, but could not be detected in neuronal perikarya. However, in reactive retinas present in retinoblastoma eyes, synaptophysin was often observed in perikarya and processes of photoreceptors. Positive neoplastic cells were found in 45 of the 54 retinoblastomas. Differentiated tumors tended to contain greater numbers of positive cells than undifferentiated ones, a third of which were entirely negative. Identical immunoreactivity was seen in frozen specimens from human retina and from three retinoblastomas. Using Western blotting, a major polypeptide comigrating with human brain synaptophysin was detected in human retina, and a similar but slightly slower migrating band in retinoblastoma. The results support a primarily neuronal origin for this tumor and point to the possibility that synaptic elements, previously observed in a few cases, may be more frequent in retinoblastoma than had been thought.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2464554

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Cellular fibronectin and tenascin in an orbital nylon prosthesis removed because of infection caused by Staphylococcus aureus.

Authors:  T Päällysaho; K Tervo; T Kivelä; I Virtanen; A Tarkkanen; T Tervo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

2.  Immunohistochemical localization of synaptophysin (p38) in the pineal gland of the Mongolian gerbil (Meriones unguiculatus).

Authors:  P Redecker; D Grube; R Jahn
Journal:  Anat Embryol (Berl)       Date:  1990

Review 3.  Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

4.  Differential expression of syntaxin-1 and synaptophysin in the developing and adult human retina.

Authors:  T C Nag; S Wadhwa
Journal:  J Biosci       Date:  2001-06       Impact factor: 1.826

5.  Neuronal and glial properties of a murine transgenic retinoblastoma model.

Authors:  T Kivelä; I Virtanen; D M Marcus; J M O'Brien; J L Carpenter; E Brauner; A Tarkkanen; D M Albert
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

6.  Mice lacking synaptophysin reproduce and form typical synaptic vesicles.

Authors:  L G Eshkind; R E Leube
Journal:  Cell Tissue Res       Date:  1995-12       Impact factor: 5.249

7.  Glutamate immunoreactivity is enriched over pinealocytes of the gerbil pineal gland.

Authors:  P Redecker; R W Veh
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

8.  Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site.

Authors:  Hemanth Ravishankar; Abubakar Siddiq Mangani; M Bhavani Shankar; Mayur Joshi; T Devasena; Sowmya Parameswaran; Krishnakumar Subramaniam
Journal:  Histochem Cell Biol       Date:  2019-11-28       Impact factor: 4.304

9.  Immunohistochemical features of the human retina and retinoblastoma.

Authors:  K Yuge; M Nakajima; Y Uemura; H Miki; M Uyama; A Tsubura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Post-translational processing of synaptophysin in the rat retina is disrupted by diabetes.

Authors:  Travis S D'Cruz; Brittany N Weibley; Scot R Kimball; Alistair J Barber
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.